Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR

Chemistry and Biology

Volumn 5, Issue 1, 1998, Pages 13-21

  Peet, Daniel J ^a   Doyle, Donald F ^a   Corey, David R ^a   Mangelsdorf, David J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Nuclear hormone receptors; Protein engineering; Retinoid X receptor; Specificity; Transcription

Indexed keywords

EID: 0031929308     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90083-7     Document Type: Article

References (46)

1. Mangelsdorf, D.J., et al., & Evans, R.M (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
2. Katzenellenbogen, J.A. & Katzenellenbogen, B.S. (1996). Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. Chem. Biol. 3, 529-536.
3. Wurtz, J.M., et al., & Gronemeyer, H. (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3, 87-94.
4. Escriva, H., et al., & Laudet, C. (1997). Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl Acad. Sci. USA 94, 6803-6808.
5. Veldscholte, J., et al., & Mulder, E. (1990). A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens. Biochem. Biophys. Res. Comm. 173, 534-540.
6. Lind, U., Carlstedt-Duke, J., Gustafsson, J.Å. & Wright, A.P. (1996). Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeast. Mol. Endocrinol. 10, 1358-1370.
7. Roux, S., et al., & Nicolas, J.C. (1996). Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor. Mol. Endocrinol. 10, 1214-1226.
8. Kohno, H., Bocchinfuso, W.P., Gandini, O., Curtis, S.W. & Korach, K.S. (1996). Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation. J. Mol. Endocrinol. 16, 277-285.
9. Ekena, K., Weis, K.E., Katzenellenbogen, J.A. & Katzenellenbogen, B.S. (1997). Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. J. Biol. Chem. 272, 5069-5075.
10. Wrenn, C.K. & Katzenellenbogen, B.S. (1993). Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem. 268, 24089-24098.
11. Uppaluri, R. & Towle, H.C. (1995). Genetic dissection of thyroid hormone receptor beta: identification of mutations that separate hormone binding and transcriptional activation. Mol. Cell Biol. 15, 1499-1512.
12. Lamour, F.P., Lardelli, P. & Apfel, C.M. (1996). Analysis of the ligand-binding domain of human retinoic acid receptor α by site-directed mutagenesis. Mol. Cell Biol. 16, 5386-5392.
13. Tate, B.F. & Grippo, J.F. (1995). Mutagenesis of the ligand binding domain of the human retinoic acid receptor α identifies critical residues for 9-cis-retinoic acid binding. J. Biol. Chem. 270, 20258-20263.
14. Zhou, Z.X., Lane, M.V., Kemppainen, J.A., French, F.S. & Wilson, E.M. (1995). Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9, 208-218.
15. Benhamou, B., et al., & Gronemeyer, H. (1992). A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255, 206-209.
16. No, D., Yao, T. & Evans, R.M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl Acad. Sci. USA 93, 3346-3351.
17. Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D. & Chambon, P. (1996). Ligand-activated site-specific recombination in mice. Proc. Natl Acad. Sci. USA 93, 10887-10890.
18. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382.
19. Renaud, J.P., et al., & Moras, D. (1995). Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
20. Wagner, R.L., Apriletti, J.W., McGrath, M.E., West, B.L., Baxter, J.D. & Fletterick, R.J. (1995). A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
21. Mangelsdorf, D.J. & Evans, R.M. (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850.
22. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
23. Boehm, M.F., et al., & Heyman, R.A. (1994). Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 37, 2930-2941.
24. Boehm, M.F., et al., & Nadzan, A.M. (1995). Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38, 3146-3155.
25. Heyman, R.A., et al., & Thaller, C. (1992). 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397-406.
26. Levin, A.A., et al., & Grippo, J.F. (1992). 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355, 359-361.
27. Canan Koch, S.S., et al., & Nadzan, A.M. (1996). Identification of the first retinoid X receptor homodimer antagonist. J. Med. Chem. 39, 3229-3234.
28. Shalinsky, D.R., et al., & Heyman, R.A. (1997). A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. Cancer Res, 57, 162-168.
29. Loeliger, P., Bollag, W. & Mayer, H. (1980). Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. 15, 9-15.
30. Perona, J.J. & Craik, C.S. (1995). Structural basis of substrate specificity in the serine proteases. Protein Sci. 4, 337-360.
31. Hedstrom, L., Szilagyi, L. & Rutter, W.J. (1992). Converting trypsin to chymotrypsin: the role of surface loops. Science 255, 1249-1253.
32. Venekei, L., Szilagyi, L., Graf, L. & Rutter, W.J. (1996). Attempts to convert chymotrypsin to trypsin. FEBS Lett. 379, 143-147.
33. Wells, J.A., Cunningham, B.C., Graycar, T.P. & Estell, D.A. (1987). Recruitment of substrate-specificity properties from one enzyme into a related one by protein engineering. Proc. Natl Acad. Sci. USA 84, 5167-5171.
34. Bone, R., Silen, J.L. & Agard, D.A. (1989). Structural plasticity broadens the specificity of an engineered protease. Nature 339, 191-195.
35. Eng, F.C.S., Lee, H.S., Ferrara, J., Willson, T.M. & White, J.H. (1997). Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics. Mol. Cell. Biol. 17, 4644-4653.
36. Weis, K.E., Ekena, K., Thomas, J.A. & Lazennec, G., Katzenellenbogen, B.S. (1996). Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10, 1388-1398.
37. Byravan, S., et al., & Stallcup, M.R. (1991). Two point mutations in the hormone-binding domain of the mouse glucocorticoid receptor that dramatically reduce its function. Mol. Endocrinol. 5, 752-758.
38. Yao, T.P., et al., & Evans, R.M. (1993). Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366, 476-479.
39. Mangelsdorf, D.J., Umesono, K., Kliewer, S.A., Borgmeyer, U., Ong, E.S. & Evans, R.M. (1991). A direct repeat in the cellular retinolbinding protein type II gene confers differential regulation by RXR and RAR. Cell 66, 555-561.
40. Petty, K.J. (1995). Tissue- and cell-specific distribution of proteins that interact with the human thyroid hormone receptor-β. Mol. Cell. Endocrinol. 108, 131-142.
41. Widom, R.L., Ladias, J.A., Kouidou, S. & Karathanasis, S.K. (1991). Synergistic interactions between transcription factors control expression of the apolipoprotein Al gene in liver cells. Mol. Cell. Biol. 11, 677-687.
42. Willy, P.J., Umesono, K., Ong, E.S., Evans, R.M., Heyman, R.A. & Mangelsdorf, D.J. (1995). LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9, 1033-1045.
43. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
44. Williams, D. & Gorski, J. (1974). Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. Biochemistry 13, 5537-5542.
45. Allegretto, E.A., et al., & Heyman, R.A. (1993). Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. J. Biol. Chem. 268, 26625-33.
46. Schreiber, E., Matthias, P., Muller, M.M. & Schaffner, W. (1989). Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419.